Tatiane Bomfim Ribeiro

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Venues

BMJ open

PloS one

Revista brasileira de epidemiologia = Brazilian journal of epidemiology

International journal of technology assessment in health care

University of Sao Paulo (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Sao Paulo Apr 1o 2018 - Mar 28o 2020

Brazil

MSC :: Faculty of Medicine, Dep of Preventive Medicine

Publications

Franciele Cordeiro Gabriel, Daniela de Oliveira Melo, Airton Tetelbom Stein, Gessica Caroline Henrique Fontes-Mota, Itamires Benício Dos Santos, Camila da Silva Rodrigues, Mônica Cristiane Rodrigues, Tatiane Bomfim Ribeiro, Renério Fráguas, Ivan D Florez, Diogo Telles Correia, Eliane Ribeiro
Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review. BMJ open 13 (3) (2023)
Franciele Cordeiro Gabriel, Daniela de Oliveira Melo, Airton Tetelbom Stein, Gessica Caroline Henrique Fontes-Mota, Itamires Benício Dos Santos, Camila da Silva Rodrigues, Mônica Cristiane Rodrigues, Tatiane Bomfim Ribeiro, Renério Fráguas, Ivan D Florez, Diogo Telles Correia, Eliane Ribeiro
Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review. BMJ open 13 (3) (2023)
Tatiane Bomfim Ribeiro, Talita Aona Mazotti, Nayara Aparecida de Oliveira Silva, Airton Tetelbom Stein, Fredi Alexander Diaz-Quijano, Daniela de Oliveira Melo
Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil. Revista brasileira de epidemiologia = Brazilian journal of epidemiology 23 (2021)
Tatiane Bomfim Ribeiro, Lewis Buss, Cole Wayant, Moacyr Roberto Cuce Nobre
Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018. PloS one 15 (7) (2020)
Tatiane Bomfim Ribeiro, Adalton Ribeiro, Luíza de Oliveira Rodrigues, Guilherme Harada, Moacyr Roberto Cuce Nobre
U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer. International journal of technology assessment in health care 36 (1) (2019)

Tatiane Bomfim Ribeiro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tatiane Bomfim Ribeiro